EBG Research Lab (Targeted Small Molecule)

Our research interest, evaluating the targeted small molecule anti-cancer agents in action, requires the analysis of their cytotoxic activities and the identification of the molecular mechanisms that these promising putative drug candidates are involved in. Fulfilling this goal exploits the abnormal signaling activities in cancer cell lines. Further investigations are envisaged to clarify the cell death mechanisms triggered by the targeted small molecule of interest.